Effect of Body Position on Hemodynamics in Patients With Acute Ischemic Stroke Undergoing Ultra-early Reperfusion Therapy
1 other identifier
interventional
100
1 country
1
Brief Summary
The aim of this study was to determine the differences in hemodynamics between different positions in patients undergoing ultra-early reperfusion therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2022
CompletedFirst Posted
Study publicly available on registry
November 16, 2022
CompletedStudy Start
First participant enrolled
December 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedMarch 1, 2024
February 1, 2024
7 months
November 10, 2022
February 29, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Differences in blood pressure variability(BPV)between different positions
BPV is defined as blood pressure oscillations in relation to the mean values.
0-7 days
Differences in heart rate variability (HRV) between different positions
HRV is defined as heart rate oscillations in relation to the mean values.
0-7 days
Secondary Outcomes (1)
The difference of middle cerebral artery blood flow velocity between different positions.
0-7 days
Study Arms (2)
Zero position
SHAM COMPARATORAll monitoring was done from 9 to 11 a.m., and the whole monitoring process was carried out in a specific and quiet environment at 20-24℃ to avoid other auditory and visual stimuli. After 10min of the relaxed supine position, the blood pressure, heart rate, and blood flow velocity of the middle cerebral artery were measured in the 0° position for 5min.
30 degrees position
EXPERIMENTALWithin 30 seconds after the 0° position measurement completion, the subjects were transferred to the 30° position and rested for 15 minutes under the 30° position. In other words, a washout period of 15 minutes was established between two measurements to ensure the stability of vital signs and avoid confounding effects. The blood pressure, heart rate, and blood flow velocity of the middle cerebral artery were measured again for 5 minutes after the vital signs were stable.
Interventions
Spontaneous arterial blood pressure will be simultaneously recorded using a servo-controlled plethysmograph on the left or right middle finger with an appropriate finger cuff size. Continuous cerebral blood flow velocities of bilateral middle cerebral artery will be assessed noninvasively using transcranial Doppler.
Eligibility Criteria
You may qualify if:
- Age≥18 years, \< 80 years, regardless of sex;
- Patients with clinically confirmed acute ischemic stroke who received intravenous thrombolysis or emergency endovascular treatment;
- Baseline National Institute of Health stroke scale(NIHSS)score ≤25;
- Baseline Glasgow Coma Scale (GCS) ≥8;
- Signed and dated informed consent is obtained
You may not qualify if:
- The patient has clear indications or contraindications, such as active vomiting, spinal cord injury;
- Clinicians considered that the assigned body position could not be maintained; Patients unable to cooperate with all noninvasive beat-by-beat continuous BP monitoring;
- Poor temporal window penetration;
- Patients with diseases that seriously affect hemodynamics, such as atrial fibrillation, anemia, and hyperthyroidism;
- Previous history of atrial fibrillation or ECG showing atrial fibrillation or arrhythmia;
- Pregnant or lactating women;
- Poor treatment compliance;
- Complicated with severe systemic diseases, such as heart failure, respiratory failure, renal failure, gastrointestinal bleeding, coagulopathy, malignant tumors.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yi Yanglead
Study Sites (1)
The First Hospital of Jilin University
Changchun, Jilin, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associated Dean of The First Hospital of Jilin University
Study Record Dates
First Submitted
November 10, 2022
First Posted
November 16, 2022
Study Start
December 1, 2022
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
March 1, 2024
Record last verified: 2024-02